Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-18

Clinical Trial Update: A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating F14 for the management of postoperative pain following total knee replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • F14

Snippet

Sponsor: Arthritis Innovation Corporation | Conditions: Post Operative Pain | Phase 3 | Status: COMPLETED